| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salmonella typhimurium | 39 | 2019 | 86 | 7.290 |
Why?
|
| Intestinal Mucosa | 46 | 2022 | 243 | 7.110 |
Why?
|
| Neutrophils | 41 | 2023 | 378 | 6.280 |
Why?
|
| Bacterial Proteins | 31 | 2021 | 775 | 4.450 |
Why?
|
| Epithelial Cells | 27 | 2021 | 401 | 3.840 |
Why?
|
| Gastrointestinal Microbiome | 14 | 2024 | 252 | 3.700 |
Why?
|
| Host-Pathogen Interactions | 13 | 2019 | 266 | 3.370 |
Why?
|
| Cell Movement | 25 | 2021 | 464 | 3.050 |
Why?
|
| Salmonella Infections | 15 | 2019 | 42 | 3.010 |
Why?
|
| Neutrophil Infiltration | 12 | 2019 | 61 | 2.900 |
Why?
|
| Microbiota | 7 | 2025 | 136 | 2.350 |
Why?
|
| Microfilament Proteins | 10 | 2017 | 112 | 2.330 |
Why?
|
| Inflammation | 21 | 2024 | 1162 | 2.170 |
Why?
|
| Shigella flexneri | 13 | 2017 | 19 | 2.140 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 13 | 2019 | 22 | 1.940 |
Why?
|
| Dysbiosis | 8 | 2022 | 71 | 1.930 |
Why?
|
| Intestines | 16 | 2021 | 169 | 1.900 |
Why?
|
| Frailty | 3 | 2021 | 125 | 1.660 |
Why?
|
| Caspase 3 | 6 | 2019 | 108 | 1.650 |
Why?
|
| Bacteria | 10 | 2025 | 317 | 1.610 |
Why?
|
| Dysentery, Bacillary | 6 | 2021 | 14 | 1.450 |
Why?
|
| Escherichia coli | 15 | 2022 | 718 | 1.430 |
Why?
|
| Transendothelial and Transepithelial Migration | 9 | 2019 | 12 | 1.260 |
Why?
|
| Lung | 6 | 2018 | 964 | 1.250 |
Why?
|
| Bacterial Adhesion | 12 | 2017 | 64 | 1.240 |
Why?
|
| Shigella | 4 | 2021 | 8 | 1.140 |
Why?
|
| Membrane Proteins | 11 | 2022 | 908 | 1.110 |
Why?
|
| Animals | 66 | 2024 | 20955 | 1.080 |
Why?
|
| Humans | 105 | 2025 | 64272 | 1.060 |
Why?
|
| Chemotactic Factors | 7 | 2021 | 26 | 1.050 |
Why?
|
| Escherichia coli Infections | 8 | 2022 | 89 | 1.010 |
Why?
|
| Cell Line | 22 | 2019 | 2057 | 1.010 |
Why?
|
| Arachidonate 12-Lipoxygenase | 8 | 2019 | 14 | 1.000 |
Why?
|
| Salmonella | 7 | 2017 | 44 | 1.000 |
Why?
|
| Phospholipases A2 | 4 | 2010 | 15 | 0.970 |
Why?
|
| Signal Transduction | 20 | 2018 | 3068 | 0.960 |
Why?
|
| Fimbriae, Bacterial | 7 | 2017 | 19 | 0.940 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2017 | 202 | 0.920 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2012 | 108 | 0.910 |
Why?
|
| Virulence Factors | 8 | 2019 | 85 | 0.880 |
Why?
|
| Immunity, Mucosal | 6 | 2010 | 52 | 0.870 |
Why?
|
| Alzheimer Disease | 5 | 2024 | 749 | 0.860 |
Why?
|
| Bacterial Infections | 6 | 2023 | 153 | 0.850 |
Why?
|
| Mice | 39 | 2024 | 10994 | 0.780 |
Why?
|
| Chemotaxis, Leukocyte | 7 | 2011 | 62 | 0.750 |
Why?
|
| Group IV Phospholipases A2 | 3 | 2017 | 5 | 0.690 |
Why?
|
| Pneumococcal Infections | 3 | 2019 | 38 | 0.680 |
Why?
|
| Cell Line, Tumor | 10 | 2025 | 1494 | 0.670 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 94 | 0.660 |
Why?
|
| Pseudomonas Infections | 3 | 2012 | 54 | 0.660 |
Why?
|
| Respiratory Mucosa | 3 | 2018 | 56 | 0.640 |
Why?
|
| Drug Resistance, Multiple | 2 | 2017 | 32 | 0.620 |
Why?
|
| Precision Medicine | 1 | 2020 | 124 | 0.610 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 275 | 0.610 |
Why?
|
| Genetic Engineering | 2 | 2017 | 117 | 0.610 |
Why?
|
| Salmonella Infections, Animal | 3 | 2010 | 10 | 0.600 |
Why?
|
| Enterocolitis | 2 | 2009 | 3 | 0.600 |
Why?
|
| Enteritis | 3 | 2009 | 13 | 0.590 |
Why?
|
| Disease Models, Animal | 10 | 2022 | 2237 | 0.570 |
Why?
|
| Endocannabinoids | 1 | 2018 | 22 | 0.570 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2018 | 28 | 0.570 |
Why?
|
| Intestinal Diseases | 2 | 2008 | 36 | 0.550 |
Why?
|
| Glycoproteins | 1 | 2019 | 189 | 0.540 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2017 | 4 | 0.540 |
Why?
|
| Mucin-1 | 1 | 2017 | 14 | 0.530 |
Why?
|
| Pneumonia, Bacterial | 2 | 2017 | 89 | 0.530 |
Why?
|
| Cadaverine | 3 | 2002 | 3 | 0.530 |
Why?
|
| Nutritional Status | 1 | 2017 | 99 | 0.520 |
Why?
|
| Tight Junctions | 4 | 2017 | 20 | 0.520 |
Why?
|
| Immunity, Innate | 8 | 2021 | 803 | 0.510 |
Why?
|
| Cecum | 5 | 2008 | 15 | 0.500 |
Why?
|
| Neoplasms | 3 | 2020 | 1393 | 0.490 |
Why?
|
| Aging | 2 | 2023 | 754 | 0.480 |
Why?
|
| Protein Kinase C | 6 | 2011 | 103 | 0.470 |
Why?
|
| Colon | 5 | 2024 | 149 | 0.470 |
Why?
|
| Cell Polarity | 10 | 2005 | 109 | 0.460 |
Why?
|
| Models, Biological | 7 | 2018 | 1187 | 0.460 |
Why?
|
| Feces | 6 | 2024 | 116 | 0.450 |
Why?
|
| Eicosanoids | 3 | 2010 | 25 | 0.450 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 221 | 0.430 |
Why?
|
| Virulence | 12 | 2014 | 195 | 0.430 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 29 | 0.430 |
Why?
|
| Gastrointestinal Tract | 2 | 2014 | 187 | 0.410 |
Why?
|
| Metal Nanoparticles | 1 | 2016 | 188 | 0.410 |
Why?
|
| Cells, Cultured | 14 | 2017 | 2177 | 0.410 |
Why?
|
| Phosphorylation | 8 | 2017 | 948 | 0.400 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2011 | 166 | 0.400 |
Why?
|
| Inflammation Mediators | 2 | 2007 | 178 | 0.400 |
Why?
|
| Gastrointestinal Diseases | 2 | 2012 | 71 | 0.400 |
Why?
|
| Asymptomatic Infections | 2 | 2025 | 29 | 0.390 |
Why?
|
| Homeostasis | 3 | 2021 | 370 | 0.390 |
Why?
|
| Interleukin-8 | 10 | 2008 | 92 | 0.390 |
Why?
|
| Peyer's Patches | 3 | 2009 | 35 | 0.390 |
Why?
|
| Bacterial Toxins | 3 | 2019 | 63 | 0.380 |
Why?
|
| Arachidonic Acid | 4 | 2017 | 35 | 0.380 |
Why?
|
| Clostridium Infections | 2 | 2024 | 49 | 0.370 |
Why?
|
| Bacterial Secretion Systems | 1 | 2011 | 10 | 0.360 |
Why?
|
| Streptomycin | 7 | 2008 | 14 | 0.360 |
Why?
|
| Cognitive Dysfunction | 3 | 2024 | 344 | 0.350 |
Why?
|
| Nursing Homes | 4 | 2024 | 672 | 0.350 |
Why?
|
| Cell Adhesion Molecules | 2 | 2007 | 92 | 0.350 |
Why?
|
| Pseudopodia | 1 | 2011 | 13 | 0.350 |
Why?
|
| Mice, Knockout | 7 | 2024 | 2138 | 0.340 |
Why?
|
| Human Development | 2 | 2020 | 9 | 0.340 |
Why?
|
| Nanoparticles | 1 | 2017 | 523 | 0.340 |
Why?
|
| Enzyme Inhibitors | 6 | 2017 | 373 | 0.340 |
Why?
|
| Health | 2 | 2020 | 31 | 0.340 |
Why?
|
| Epithelium | 5 | 2004 | 96 | 0.330 |
Why?
|
| Salmonella enterica | 2 | 2008 | 26 | 0.330 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 206 | 0.320 |
Why?
|
| Molecular Targeted Therapy | 1 | 2010 | 129 | 0.320 |
Why?
|
| Protein Transport | 5 | 2016 | 405 | 0.320 |
Why?
|
| Streptococcus pneumoniae | 3 | 2019 | 66 | 0.310 |
Why?
|
| Muramidase | 1 | 2009 | 47 | 0.310 |
Why?
|
| Probiotics | 3 | 2020 | 48 | 0.300 |
Why?
|
| Mutation | 10 | 2025 | 2633 | 0.300 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2022 | 108 | 0.300 |
Why?
|
| HeLa Cells | 9 | 2019 | 542 | 0.280 |
Why?
|
| Intestinal Neoplasms | 1 | 2008 | 14 | 0.280 |
Why?
|
| Dementia | 2 | 2023 | 263 | 0.280 |
Why?
|
| Diarrhea | 4 | 2017 | 76 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 3449 | 0.280 |
Why?
|
| Saccharomyces | 1 | 2007 | 3 | 0.280 |
Why?
|
| Anti-Bacterial Agents | 5 | 2024 | 800 | 0.280 |
Why?
|
| Lung Diseases | 2 | 2013 | 183 | 0.270 |
Why?
|
| Aged | 10 | 2025 | 14663 | 0.260 |
Why?
|
| Enterobacteriaceae | 3 | 2022 | 18 | 0.250 |
Why?
|
| Crohn Disease | 1 | 2008 | 111 | 0.250 |
Why?
|
| Cell Membrane | 5 | 2019 | 501 | 0.250 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 674 | 0.250 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2020 | 61 | 0.240 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2023 | 97 | 0.240 |
Why?
|
| Blotting, Western | 3 | 2014 | 614 | 0.240 |
Why?
|
| Phospholipases A | 1 | 2005 | 15 | 0.240 |
Why?
|
| Female | 19 | 2025 | 33383 | 0.240 |
Why?
|
| Urinary Tract Infections | 2 | 2025 | 93 | 0.230 |
Why?
|
| Cytokines | 6 | 2024 | 945 | 0.230 |
Why?
|
| Male | 21 | 2025 | 30322 | 0.230 |
Why?
|
| Urine | 1 | 2025 | 45 | 0.230 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2016 | 72 | 0.230 |
Why?
|
| Drug Delivery Systems | 3 | 2017 | 328 | 0.230 |
Why?
|
| Amino Acid Motifs | 2 | 2019 | 153 | 0.220 |
Why?
|
| Succinic Acid | 1 | 2024 | 12 | 0.220 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 5528 | 0.220 |
Why?
|
| Hyperplasia | 1 | 2024 | 89 | 0.220 |
Why?
|
| Colitis | 2 | 2021 | 78 | 0.220 |
Why?
|
| Cognitive Aging | 1 | 2023 | 4 | 0.210 |
Why?
|
| Antigen Presentation | 1 | 2006 | 241 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 1 | 2025 | 417 | 0.210 |
Why?
|
| Plasmids | 4 | 2017 | 293 | 0.200 |
Why?
|
| Chemokines | 3 | 1999 | 93 | 0.200 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 313 | 0.200 |
Why?
|
| Gastroenteritis | 2 | 2010 | 14 | 0.200 |
Why?
|
| Monocytes | 2 | 2022 | 357 | 0.200 |
Why?
|
| Chemotaxis | 4 | 2007 | 49 | 0.200 |
Why?
|
| Actins | 4 | 2016 | 261 | 0.200 |
Why?
|
| Goblet Cells | 1 | 2022 | 8 | 0.190 |
Why?
|
| Adhesins, Escherichia coli | 2 | 2012 | 3 | 0.190 |
Why?
|
| Butyrates | 1 | 2022 | 16 | 0.190 |
Why?
|
| Escherichia coli Proteins | 4 | 2007 | 275 | 0.190 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2022 | 41 | 0.190 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 24 | 0.190 |
Why?
|
| Piperidines | 1 | 2002 | 66 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 4 | 2017 | 891 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2022 | 105 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 217 | 0.180 |
Why?
|
| Vacuoles | 2 | 2011 | 26 | 0.180 |
Why?
|
| Insulins | 1 | 2022 | 15 | 0.180 |
Why?
|
| Diet | 2 | 2022 | 533 | 0.180 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2001 | 20 | 0.180 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 176 | 0.180 |
Why?
|
| Phagosomes | 1 | 2001 | 54 | 0.170 |
Why?
|
| Interleukin-6 | 1 | 2002 | 325 | 0.170 |
Why?
|
| Digestive System Diseases | 1 | 2020 | 14 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2019 | 3318 | 0.170 |
Why?
|
| Mammals | 1 | 2022 | 219 | 0.170 |
Why?
|
| Ubiquitination | 1 | 2021 | 113 | 0.170 |
Why?
|
| Immune System Diseases | 1 | 2020 | 19 | 0.170 |
Why?
|
| Myeloid Cells | 1 | 2021 | 94 | 0.170 |
Why?
|
| DNA | 1 | 2025 | 844 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 58 | 0.160 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2019 | 3 | 0.160 |
Why?
|
| Streptolysins | 1 | 2019 | 10 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2011 | 43 | 0.160 |
Why?
|
| Carboxy-Lyases | 1 | 1999 | 6 | 0.160 |
Why?
|
| Arachidonic Acids | 2 | 2011 | 27 | 0.160 |
Why?
|
| Down-Regulation | 3 | 2017 | 320 | 0.160 |
Why?
|
| Rats | 1 | 2023 | 2005 | 0.150 |
Why?
|
| Cell Migration Assays, Leukocyte | 2 | 2009 | 2 | 0.150 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2020 | 58 | 0.150 |
Why?
|
| Metagenomics | 1 | 2019 | 28 | 0.150 |
Why?
|
| Bacteremia | 2 | 2017 | 94 | 0.150 |
Why?
|
| Bacterial Load | 1 | 2019 | 29 | 0.150 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 625 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 667 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 96 | 0.150 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2018 | 10 | 0.140 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 37 | 0.140 |
Why?
|
| Peptic Ulcer Perforation | 1 | 2018 | 5 | 0.140 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 1272 | 0.140 |
Why?
|
| Protein Kinase C-alpha | 2 | 2011 | 16 | 0.140 |
Why?
|
| Incidence | 1 | 2022 | 1386 | 0.140 |
Why?
|
| Carbazoles | 2 | 2011 | 14 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 87 | 0.140 |
Why?
|
| Microvilli | 2 | 2016 | 5 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2011 | 46 | 0.140 |
Why?
|
| Protein Domains | 1 | 2019 | 154 | 0.140 |
Why?
|
| Chlorobenzoates | 1 | 2017 | 1 | 0.140 |
Why?
|
| Cyclohexanones | 1 | 2017 | 4 | 0.140 |
Why?
|
| ortho-Aminobenzoates | 1 | 2017 | 7 | 0.140 |
Why?
|
| Cell Communication | 2 | 2010 | 132 | 0.140 |
Why?
|
| Cinnamates | 1 | 2017 | 9 | 0.140 |
Why?
|
| Tetrathionic Acid | 1 | 2017 | 2 | 0.140 |
Why?
|
| Antibiosis | 1 | 2017 | 4 | 0.140 |
Why?
|
| Insurance Coverage | 1 | 2018 | 99 | 0.130 |
Why?
|
| Dinoprostone | 2 | 2023 | 43 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 458 | 0.130 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 1997 | 3 | 0.130 |
Why?
|
| Permeability | 1 | 2017 | 50 | 0.130 |
Why?
|
| Adhesins, Bacterial | 1 | 1997 | 10 | 0.130 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 374 | 0.130 |
Why?
|
| Machine Learning | 1 | 2019 | 184 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2010 | 386 | 0.130 |
Why?
|
| Integrin beta1 | 1 | 1997 | 32 | 0.130 |
Why?
|
| Nanomedicine | 1 | 2017 | 24 | 0.130 |
Why?
|
| Nod1 Signaling Adaptor Protein | 2 | 2008 | 13 | 0.130 |
Why?
|
| Insurance, Health | 1 | 2018 | 151 | 0.130 |
Why?
|
| Macrophages | 3 | 2017 | 1053 | 0.130 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 260 | 0.130 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2016 | 2 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2017 | 587 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2017 | 174 | 0.120 |
Why?
|
| Type III Secretion Systems | 1 | 2016 | 4 | 0.120 |
Why?
|
| NF-kappa B | 2 | 2008 | 471 | 0.120 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 27 | 0.120 |
Why?
|
| Doxorubicin | 1 | 2016 | 101 | 0.120 |
Why?
|
| Zonula Occludens-1 Protein | 3 | 2007 | 7 | 0.120 |
Why?
|
| Receptors, Chemokine | 2 | 2006 | 33 | 0.120 |
Why?
|
| Actin Cytoskeleton | 1 | 2016 | 77 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2022 | 85 | 0.120 |
Why?
|
| Intestine, Large | 2 | 1996 | 7 | 0.120 |
Why?
|
| Gene Deletion | 4 | 2009 | 312 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2010 | 1597 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2010 | 1999 | 0.110 |
Why?
|
| Base Sequence | 3 | 2010 | 1335 | 0.110 |
Why?
|
| Fimbriae Proteins | 2 | 2005 | 14 | 0.110 |
Why?
|
| Drug Carriers | 1 | 2017 | 181 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2017 | 626 | 0.110 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2015 | 67 | 0.110 |
Why?
|
| Cell Death | 1 | 2016 | 286 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 929 | 0.110 |
Why?
|
| Extracellular Matrix | 1 | 1995 | 139 | 0.110 |
Why?
|
| NAD | 2 | 2022 | 52 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 68 | 0.110 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2014 | 13 | 0.110 |
Why?
|
| Genetic Complementation Test | 3 | 2009 | 63 | 0.110 |
Why?
|
| Phosphoproteins | 3 | 2007 | 221 | 0.110 |
Why?
|
| Gold | 1 | 2016 | 233 | 0.110 |
Why?
|
| Arachidonate 15-Lipoxygenase | 2 | 2017 | 8 | 0.110 |
Why?
|
| Immune Evasion | 1 | 2014 | 68 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 3 | 2007 | 460 | 0.100 |
Why?
|
| Cell Migration Inhibition | 2 | 2004 | 7 | 0.100 |
Why?
|
| Genomic Islands | 2 | 2011 | 8 | 0.100 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2024 | 20 | 0.100 |
Why?
|
| Mucus | 3 | 2000 | 15 | 0.100 |
Why?
|
| Peptides | 1 | 2017 | 590 | 0.100 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2013 | 7 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2017 | 303 | 0.100 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2013 | 21 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 237 | 0.100 |
Why?
|
| Blood-Air Barrier | 1 | 2012 | 1 | 0.100 |
Why?
|
| Toll-Like Receptors | 2 | 2005 | 432 | 0.100 |
Why?
|
| Protein Kinase C-delta | 1 | 2012 | 8 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 416 | 0.100 |
Why?
|
| Integrases | 1 | 1993 | 38 | 0.100 |
Why?
|
| Respiratory Burst | 2 | 2022 | 21 | 0.100 |
Why?
|
| Biological Transport | 2 | 2004 | 291 | 0.090 |
Why?
|
| Protein Binding | 2 | 2015 | 1619 | 0.090 |
Why?
|
| Dendritic Cells | 2 | 2006 | 529 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 430 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 869 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1000 | 0.090 |
Why?
|
| Middle Aged | 7 | 2025 | 17923 | 0.090 |
Why?
|
| Schizophrenia | 1 | 2014 | 266 | 0.090 |
Why?
|
| Transfection | 3 | 2011 | 696 | 0.090 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1992 | 14 | 0.090 |
Why?
|
| Benzophenanthridines | 1 | 2011 | 2 | 0.090 |
Why?
|
| Cytoplasm | 2 | 2010 | 279 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 1195 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 671 | 0.090 |
Why?
|
| Colony Count, Microbial | 2 | 2007 | 59 | 0.090 |
Why?
|
| Transplantation, Heterologous | 2 | 2012 | 240 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1301 | 0.090 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2010 | 1 | 0.090 |
Why?
|
| Mice, SCID | 2 | 2012 | 517 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 152 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2010 | 105 | 0.080 |
Why?
|
| Claudin-1 | 2 | 2007 | 3 | 0.080 |
Why?
|
| Occludin | 2 | 2007 | 3 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 268 | 0.080 |
Why?
|
| Serum Albumin | 1 | 1989 | 46 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 298 | 0.080 |
Why?
|
| Genes, Bacterial | 4 | 2007 | 120 | 0.080 |
Why?
|
| Species Specificity | 2 | 2008 | 334 | 0.080 |
Why?
|
| Cadherins | 2 | 2007 | 82 | 0.080 |
Why?
|
| Apoptosis | 1 | 2014 | 1095 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2001 | 402 | 0.070 |
Why?
|
| Chemokines, CXC | 1 | 2008 | 29 | 0.070 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 37 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 178 | 0.070 |
Why?
|
| Serotyping | 4 | 2005 | 53 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 62 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2008 | 6 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 143 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2008 | 141 | 0.070 |
Why?
|
| Leukotriene B4 | 1 | 2007 | 12 | 0.070 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2007 | 3 | 0.070 |
Why?
|
| Collagen Type I | 1 | 2008 | 41 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 60 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 45 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2007 | 36 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2008 | 634 | 0.070 |
Why?
|
| Quinolinic Acids | 1 | 2007 | 2 | 0.070 |
Why?
|
| Dogs | 3 | 2008 | 332 | 0.070 |
Why?
|
| Fibrosis | 1 | 2008 | 162 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1131 | 0.070 |
Why?
|
| Bacillus subtilis | 2 | 2019 | 31 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 153 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2008 | 375 | 0.060 |
Why?
|
| Time Factors | 4 | 2008 | 3725 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 1297 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2008 | 17 | 0.060 |
Why?
|
| Bacterial Typing Techniques | 1 | 2006 | 12 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2006 | 22 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2008 | 404 | 0.060 |
Why?
|
| Brain | 1 | 2014 | 1581 | 0.060 |
Why?
|
| Nematospiroides dubius | 1 | 2005 | 4 | 0.060 |
Why?
|
| Strongylida Infections | 1 | 2005 | 5 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2006 | 123 | 0.060 |
Why?
|
| Citrobacter rodentium | 1 | 2005 | 5 | 0.060 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2005 | 11 | 0.060 |
Why?
|
| Bacteriuria | 1 | 2025 | 16 | 0.060 |
Why?
|
| Urinalysis | 1 | 2025 | 38 | 0.060 |
Why?
|
| Genome, Mitochondrial | 1 | 2025 | 12 | 0.060 |
Why?
|
| Swine Diseases | 1 | 2005 | 4 | 0.060 |
Why?
|
| Enterotoxins | 1 | 2005 | 21 | 0.060 |
Why?
|
| Base Pairing | 1 | 2025 | 45 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2007 | 417 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 239 | 0.060 |
Why?
|
| Equol | 1 | 2024 | 5 | 0.060 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 43 | 0.060 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 88 | 0.060 |
Why?
|
| Cytosol | 1 | 2005 | 181 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 756 | 0.050 |
Why?
|
| Metabolomics | 1 | 2024 | 57 | 0.050 |
Why?
|
| Membranes | 1 | 2004 | 18 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 68 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2003 | 12 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 705 | 0.050 |
Why?
|
| Hydroxy Acids | 1 | 2023 | 2 | 0.050 |
Why?
|
| Bacteroides fragilis | 1 | 2023 | 5 | 0.050 |
Why?
|
| Bacteroides | 1 | 2023 | 9 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 761 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2025 | 226 | 0.050 |
Why?
|
| Indoles | 1 | 2004 | 115 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2004 | 296 | 0.050 |
Why?
|
| Yersinia | 1 | 2003 | 3 | 0.050 |
Why?
|
| Porphyromonas gingivalis | 1 | 2003 | 17 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 27 | 0.050 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2003 | 20 | 0.050 |
Why?
|
| Enterocytes | 1 | 2003 | 23 | 0.050 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1999 | 19 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1561 | 0.050 |
Why?
|
| Lactoferrin | 1 | 2002 | 37 | 0.050 |
Why?
|
| NADP | 1 | 2022 | 22 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 56 | 0.050 |
Why?
|
| Peroxidase | 1 | 2002 | 70 | 0.050 |
Why?
|
| NADPH Oxidases | 1 | 2022 | 70 | 0.050 |
Why?
|
| Carbapenems | 1 | 2022 | 7 | 0.050 |
Why?
|
| Prebiotics | 1 | 2022 | 18 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 28 | 0.050 |
Why?
|
| Phospholipase D | 1 | 2001 | 6 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 41 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 432 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1622 | 0.040 |
Why?
|
| Klebsiella pneumoniae | 1 | 2022 | 30 | 0.040 |
Why?
|
| Bacteriocins | 1 | 2022 | 23 | 0.040 |
Why?
|
| Flavonoids | 1 | 2002 | 75 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 312 | 0.040 |
Why?
|
| Weight Gain | 1 | 2022 | 168 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 1019 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2001 | 139 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 342 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 49 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 44 | 0.040 |
Why?
|
| Pregnancy | 1 | 2007 | 2370 | 0.040 |
Why?
|
| Microglia | 1 | 2023 | 250 | 0.040 |
Why?
|
| DNA Primers | 1 | 2000 | 295 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 132 | 0.040 |
Why?
|
| Eukaryotic Cells | 1 | 2000 | 57 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2022 | 576 | 0.040 |
Why?
|
| Clostridium septicum | 1 | 2019 | 1 | 0.040 |
Why?
|
| Dysentery | 1 | 1999 | 1 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2001 | 1541 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2022 | 1552 | 0.040 |
Why?
|
| Escherichia coli O157 | 1 | 1999 | 20 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2000 | 200 | 0.040 |
Why?
|
| Cell Size | 1 | 1999 | 41 | 0.040 |
Why?
|
| Lysine | 1 | 1999 | 87 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 209 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 709 | 0.040 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1998 | 1 | 0.040 |
Why?
|
| Lipoxins | 1 | 1998 | 7 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2018 | 41 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2605 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 1999 | 183 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 333 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 1020 | 0.040 |
Why?
|
| Receptors, Interleukin-8A | 1 | 1998 | 3 | 0.030 |
Why?
|
| Receptors, Formyl Peptide | 1 | 1998 | 6 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 1998 | 20 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2000 | 348 | 0.030 |
Why?
|
| Biomarkers | 1 | 2023 | 1431 | 0.030 |
Why?
|
| Superoxides | 1 | 1998 | 72 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1998 | 38 | 0.030 |
Why?
|
| Cognition | 1 | 2022 | 491 | 0.030 |
Why?
|
| Disk Diffusion Antimicrobial Tests | 1 | 2017 | 2 | 0.030 |
Why?
|
| Receptors, Peptide | 1 | 1998 | 34 | 0.030 |
Why?
|
| Gene Order | 1 | 2017 | 32 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1998 | 203 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 1998 | 179 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 1118 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 2017 | 156 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 1407 | 0.030 |
Why?
|
| Antigens, CD | 1 | 1998 | 348 | 0.030 |
Why?
|
| Integrins | 2 | 1998 | 109 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 870 | 0.030 |
Why?
|
| Ceramides | 1 | 2016 | 24 | 0.030 |
Why?
|
| United States | 2 | 2019 | 7923 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 1996 | 136 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 582 | 0.030 |
Why?
|
| Medicare | 1 | 2019 | 611 | 0.030 |
Why?
|
| Gene Expression | 3 | 2004 | 851 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1995 | 212 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 1996 | 192 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 179 | 0.030 |
Why?
|
| Shiga Toxin | 1 | 2014 | 4 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 1248 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2018 | 870 | 0.030 |
Why?
|
| Nucleoside-Diphosphate Kinase | 1 | 1993 | 3 | 0.030 |
Why?
|
| Genes, Switch | 1 | 1993 | 6 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 197 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 68 | 0.020 |
Why?
|
| Operon | 1 | 1993 | 34 | 0.020 |
Why?
|
| Proteins | 2 | 2002 | 760 | 0.020 |
Why?
|
| Chromosome Inversion | 1 | 1993 | 18 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2013 | 116 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 150 | 0.020 |
Why?
|
| Phagocytosis | 2 | 2005 | 266 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 1993 | 42 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2012 | 47 | 0.020 |
Why?
|
| Receptors, Cytoadhesin | 1 | 1992 | 2 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 2 | 1988 | 48 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1992 | 36 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 386 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 245 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 1992 | 210 | 0.020 |
Why?
|
| Gastrointestinal Motility | 1 | 1990 | 8 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1992 | 176 | 0.020 |
Why?
|
| Mannose | 1 | 1989 | 22 | 0.020 |
Why?
|
| Sulfides | 1 | 1989 | 24 | 0.020 |
Why?
|
| Cephalosporins | 1 | 1969 | 18 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 1989 | 35 | 0.020 |
Why?
|
| Adolescent | 2 | 2018 | 6306 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2008 | 4 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 116 | 0.020 |
Why?
|
| Culture Media | 1 | 1988 | 79 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 248 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 4782 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6741 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5696 | 0.020 |
Why?
|
| Multigene Family | 1 | 2007 | 102 | 0.020 |
Why?
|
| Iron-Binding Proteins | 1 | 2006 | 11 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2006 | 24 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2006 | 84 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2008 | 233 | 0.020 |
Why?
|
| Receptors, CCR6 | 1 | 2006 | 9 | 0.020 |
Why?
|
| Cysteine | 1 | 2006 | 108 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 365 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 149 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2005 | 8 | 0.010 |
Why?
|
| Queensland | 1 | 2005 | 1 | 0.010 |
Why?
|
| Chemokines, CX3C | 1 | 2005 | 4 | 0.010 |
Why?
|
| Chemokine CX3CL1 | 1 | 2005 | 8 | 0.010 |
Why?
|
| Ileum | 1 | 2005 | 21 | 0.010 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2005 | 13 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2005 | 55 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 224 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 245 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 173 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2005 | 80 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 668 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 395 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 247 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 519 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 312 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 375 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2004 | 140 | 0.010 |
Why?
|
| HT29 Cells | 1 | 2003 | 30 | 0.010 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2003 | 26 | 0.010 |
Why?
|
| Caco-2 Cells | 1 | 2003 | 71 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 312 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 17136 | 0.010 |
Why?
|
| Symbiosis | 1 | 2003 | 32 | 0.010 |
Why?
|
| Zonula Occludens-2 Protein | 1 | 2002 | 2 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 677 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 1164 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2001 | 22 | 0.010 |
Why?
|
| Lac Repressors | 1 | 2000 | 2 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 71 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 2000 | 29 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 1223 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 2000 | 49 | 0.010 |
Why?
|
| Endocytosis | 1 | 2001 | 153 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2000 | 78 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 89 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 302 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 316 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1998 | 70 | 0.010 |
Why?
|
| Drug Stability | 1 | 1998 | 144 | 0.010 |
Why?
|
| Child | 2 | 2003 | 4583 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 684 | 0.010 |
Why?
|
| Kinetics | 1 | 1998 | 766 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1998 | 679 | 0.010 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 1993 | 4 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1993 | 21 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 66 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1969 | 2019 | 0.000 |
Why?
|